Nature communications · 2025
Regulatory T cells in the mouse hypothalamus control immune activation and ameliorate metabolic impairments in high-calorie environments.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Becker Maike, Kälin Stefanie, Neubig Anne H, Lauber Michael, Opaleva Daria, Hipp Hannah, Salb Victoria K, Ott Verena B, Legutko Beata, Kälin Roland E, Hippich Markus, Scherm Martin G, Nascimento Lucas F R, Serr Isabelle, Hosp Fabian, Nikolaev Alexei, Mohebiany Alma, Krueger Martin, Flachmeyer Bianca, Pfaffl Michael W, Haase Bettina, Yi Chun-Xia, Dietzen Sarah, Bopp Tobias, Woods Stephen C, Waisman Ari, Weigmann Benno, Mann Matthias, Tschöp Matthias H, Daniel Carolin
Аннотация
The hypothalamus in the central nervous system (CNS) has important functions in controlling systemic metabolism. A calorie-rich diet triggers CNS immune activation, impairing metabolic control and promoting obesity and Type 2 Diabetes (T2D), but the mechanisms driving hypothalamic immune activation remain unclear. Here we identify regulatory T cells (Tregs) as key modulators of hypothalamic immune responses. In mice, calorie-rich environments activate hypothalamic CD4+ T cells, infiltrating macrophages and microglia while reducing hypothalamic Tregs. mRNA profiling of hypothalamic CD4+ T cells reveals a Th1-like activation state, with increased Tbx21, Cxcr3 and Cd226 but decreased Ccr7 and S1pr1. Importantly, results from Treg loss-of function and gain-of-function experiments show that Tregs limit hypothalamic immune activation and reverse metabolic impairments induced by hyper-caloric feeding. Our findings thus help refine the current model of Treg-centered immune-metabolic crosstalk in the brain and may contribute to the development of precision immune modulation for obesity and diabetes.